Skip to main content
Search
News, Views, and Advocacy From the Oncology Nursing Society
ONS Voice Home
  • News & Views
  • Advocacy
  • Stories
  • Instagram
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • RSS
  • News & Views
    • Latest Articles
    • Clinical Practice
    • ONS News
    • ONS Leadership
    Trending Topics
    • Research
    • Treatments
    • Safety
    • COVID-19
    • Drug Reference Sheet
    • Special Populations
    View All Topics
    Advocacy
    • Latest Articles
    • Updates
    • Get Involved
    Stories View All
    View All
    Innovative Oncology Nurses Break Down Communication Barriers for Patients Who Are Deaf or Hard of Hearing
    Special Populations
    Innovative Oncology Nurses Break Down Communication Barriers for Patients Who Are Deaf or Hard of Hearing
    March 10, 2023
    How I Practice Mindfulness as an Oncology Nurse
    Nurse well-being
    How I Practice Mindfulness as an Oncology Nurse
    March 03, 2023
    Clinical and Pharmaceutical Nurse Educators Collaborate to Bring Training to Nurses and Improve Patient Care
    Oncology nurse education
    Clinical and Pharmaceutical Nurse Educators Collaborate to Bring Training to Nurses and Improve Patient Care
    January 13, 2023
    Oncology Nurse Uses Retirement to Help Patients and Healthcare Professionals Understand Pancreatic Cancer Biomarker Testing Results
    Pancreatic cancer
    Oncology Nurse Uses Retirement to Help Patients and Healthcare Professionals Understand Pancreatic Cancer Biomarker Testing Results
    November 11, 2022
    The Life of Marie Curie and Her Contributions to Oncology
    Cancer treatments
    The Life of Marie Curie and Her Contributions to Oncology
    November 07, 2022
    previous slide
    next slide
    Search
  • News & Views
  • Advocacy
  • Stories
  • Topic

    Patient reported outcomes (PROs)

    Don’t Ask Patients About Their Symptoms—Have Them Tell You
    Symptom management

    Don’t Ask Patients About Their Symptoms—Have Them Tell You

    “How are you doing?” We ask this question of our patients repeatedly: at diagnosis, during treatment, throughout survivorship, and at end of life. However, studies show that patients often give inaccurate answers to that direct question.

    May 12, 2022
    ONS Congress

    Social and Economic Factors Have a Bigger Influence on Health Outcomes Than Clinical Care

    Between 10%–20% of health outcomes are a direct result of clinical care, whereas 40% are attributed to social and economic factors such as education, employment, income, family and social support, and community safety, speakers said during a session for the 46th Annual ONS Congress™ on April 20, 2021. The remaining 40%–50% correlate with health behaviors, physical environment, and genes and biology, they said.

    April 20, 2021
    Radiation Clinical Trials Must Evolve to Include Patient-Reported Outcomes
    Radiation therapy

    Radiation Clinical Trials Must Evolve to Include Patient-Reported Outcomes

    Prostate cancer is one of the most common cancers treated with radiotherapy (RT). Conventional RT for low-risk patients usually involves 40–45 treatments given over eight or nine weeks. Several studies suggest that hypofractionated RT—fewer treatments but with a higher dose per treatment—may produce a similar survival benefit. When two treatments have similar survival outcomes, the decision process looks at symptom profiles, quality of life, and cost.

    October 14, 2020
    ONS Bridge

    Oncology Symptom Science Research Needs to Focus on New Therapies

    Immunotherapy, emerging therapies, precision health, and biosignatures are the next frontier for oncology symptom science research, specifically patient-reported outcomes and immune-related adverse events, researchers reported during a presentation on September 8, 2020, at the inaugural ONS Bridge™ virtual conference.

    September 08, 2020
    Treating Mental Health May Improve Lung Cancer Survival
    Cancer research

    Treating Mental Health May Improve Lung Cancer Survival

    Patients with lung cancer who also had mental health disorders saw improved cancer-related outcomes when their mental illness was treated, according to findings from a study published in JAMA Oncology.

    September 02, 2020
    Early Use of Immunotherapy Has Better Outcomes for Bladder Cancer
    Immunotherapy

    Early Use of Immunotherapy Has Better Outcomes for Bladder Cancer

    Starting immunotherapy for bladder cancer shortly after initial treatment with chemotherapy is better than taking an extended break from cancer treatment, according to results from a study reported at the American Society of Clinical Oncology annual meeting.

    August 12, 2020
    FDA Announces Program on PROs From Cancer Clinical Trials
    U.S. Food and Drug Administration (FDA)

    FDA Program Shares PROs From Cancer Clinical Trials

    Cancer clinical trials often collect patient-reported outcome (PRO) data, but the information is generally used just for that trial. Recognizing the value of making it available to healthcare providers everywhere, in July 2020, the U.S. Food and Drug Administration (FDA) launched Project Patient Voice, a pilot program designed to share clinical trial PROs on an easy-to-access website.

    August 11, 2020
    FDA Launches Pilot Program on Patient-Reported Outcomes
    Patient reported outcomes (PROs)

    FDA Launches Pilot Program on Patient-Reported Outcomes

    Facilitating the provision of patient-centered care is an ONS priority. But until recently, quality information from the patient’s perspective was limited. This kind of information is often unavailable, limited in its breadth, or solicited from patients too late in the healthcare process, making their experience less understandable than necessary. In response, the U.S. Food and Drug Administration’s (FDA’s) Oncology Center of Excellence created a pilot program, called Project Patient Voice, that will make patient-reported symptoms from cancer trials available to the public.

    July 08, 2020
    Dietary Supplements May Affect Breast Cancer Chemo Outcomes
    Chemotherapy

    Dietary Supplements May Affect Breast Cancer Chemo Outcomes

    Antioxidant supplements are associated with increased disease recurrence and statistically nonsignificant increased risk of mortality in patients with breast cancer who were receiving cyclophosphamide, doxorubicin, and paclitaxel, according to findings from a study reported in the Journal of Clinical Oncology.

    May 13, 2020
    San Antonio Breast Cancer Symposium

    Patients Rank the Importance of PRO Measures Differently

    Patient-reported outcomes (PROs) can improve patient satisfaction and potentially impact survival. However, PRO data are not well-collected outside of the research setting. Researchers at the Yale School of Medicine in New Haven, CT, conducting qualitative study assessed the most personally relevant PROs in women with metastatic breast cancer and observed substantial variation in patient preferences. They presented the findings at the San Antonio Breast Cancer Symposium on December 7, 2018.

    December 07, 2018
    How Is CTCAE Improving Research and Patient Care?
    Oncology clinical trials

    How Is CTCAE Improving Research and Patient Care?

    The Common Terminology Criteria for Adverse Events (CTCAE) is a list of adverse event (AE) terms most often encountered in oncology. It’s been in ongoing development since the 1980s and was previously referred to as the Common Toxicity Criteria. Through continual development and support from the National Cancer Institute’s Cancer Therapy Evaluation Program, CTCAE aids in the documentation and analysis of adverse events in oncology-related clinical trials.  

    August 01, 2018
    ONS Congress

    Nurses Are Advancing Research in Data-Powered Science

    Nurses can foster data-powered health through getting involved in research and ensuring that data collection is in patients’ best interest and accessible to all. Patricia Brennan, PhD, RN, director of the National Library of Medicine, and Suzanne Bakken, PhD, RN, FAAN, a professor at Columbia University, discussed how data can empower health and what nurses can do to advance research during a session at the 43rd Annual Congress in Washington, DC.

    May 18, 2018
    American Society of Hematology Annual Meeting

    Activity Tracker Data Correlates With Patient-Reported Outcomes

    Patient-reported outcomes (PROs) are an important part of patient management but may be burdensome for patients to track. Wearable activity monitors provide objective, continuous activity data that may correlate with PROs, and researchers assessed the use of this technology in a study. Carrie A. Thompson, MD, at the Mayo Clinic in Rochester, MN, discussed the findings at the ASH Annual Meeting.

    December 09, 2017
    Ethan Basch
    Patient reported outcomes (PROs)

    What Does the Evidence Show About Patient-Reported Outcomes, Quality of Life, and Survival?

    Patients know their own experiences best. Evidence has shown that providers are unaware of about half of patients’ symptoms during cancer care. When patients directly report their symptoms using online questionnaires, it can help close this gap in communication. Bringing the patient voice into practice using patient-reported outcomes (PROs) can not only make us aware of their symptoms—enabling earlier interventions—but can also make care delivery more patient-centered.

    August 01, 2017
    improving oncology care through patient reported outcomes
    Patient reported outcomes (PROs)

    Improving Cancer Care Through Patient-Reported Outcomes

    Technology can—at times—seem miraculous, especially as it evolves in healthcare settings. Simple technologic tools have been able to lower costs, increase efficiency, minimize delays in treatment times, and even provide new, lifesaving procedures for cancer treatment.

    August 01, 2017
    ASCO Annual Meeting

    Adverse Events Influence Patient-Reported Quality-of-Life Scores

    Researchers conducted a single-center, cross-sectional study to examine the relationship between patient-reported quality-of-life (QOL), adverse events (AEs), and treatment characteristics (including tumor type, drug class, number of cycles, and treatment intent). The study’s findings were presented at the 2017 ASCO Annual Meeting.

    June 05, 2017
    ASCO Annual Meeting

    Discussion About Goals of Care May Improve Patient Understanding

    Discussing goals of care with patients with advanced cancer can provide better information on the disease, treatment options, and prognosis, as well as elicit patient values. A randomized, controlled trial tested a coaching model to improve healthcare providers’ communication on goals of care. The study’s findings were presented at the 2017 ASCO Annual Meeting.

    June 05, 2017
    ASCO Annual Meeting

    Patient-Reported Tool to Evaluate Distress Predicts Survival

    The Living With Cancer (LWC) patient-reported outcome (PRO) tool evaluates distress in patients with advanced cancer using a seven-item Likert survey to measure performance status, pain, burden (financial and family), and depression, with scores ranging from 0–112.

    June 03, 2017
    ONS Congress

    Using Patient-Reported Outcomes Improves Symptoms in Adults With Acute Leukemia

    Ashley Bryant, PhD, RN, OCN®, assistant professor at the University of North Carolina at Chapel Hill School of Nursing, was the recipient of the 2017 Victoria Mock New Investigator Award and gave a lecture at the 42nd Annual Congress in Denver, CO, on her work on patient-reported symptoms and quality of life.

    May 06, 2017
    Nursing evidence-based practice

    How Oncology Nursing Research Impacts Healthcare Policy

    Policy advocates and researchers are often conceptualized as separate roles that rarely, if ever, cross. However, in reality many researchers may not have started out as policy advocates, but based on their research findings, or use of research findings in practice, have impacted the world of healthcare policy.
    March 01, 2016
    Trending Topics
    • Research
    • Treatments
    • Safety
    • COVID-19
    • Drug Reference Sheet
    • Special Populations
    • Clinical practice
    • U.S. Food and Drug Administration (FDA)
    • Health Policy
    • Immunotherapy
    View All Topics
     
    Home
    News, Views, and Advocacy From the Oncology Nursing Society
  • Legal Notices
  • Contact Us
  • Conferences
  • Advertising
  • Newsroom
  • Sitemap
  • Instagram
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • RSS
  • ONS
  • Oncology Nursing Foundation
  • ONCC
  • © Copyright 2023 Oncology Nursing Society
     
    Back to Top ▲